Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines.

ABSTRACT:

Background

The World Health Organization (WHO) recommends oxytocin as the drug of choice for postpartum hemorrhage (PPH) prevention. However, the WHO has also recently considered carbetocin for PPH prevention, but only if carbetocin were a cost-effective choice in the country. Consequently, we determined the cost-effectiveness and budgetary impact of carbetocin against oxytocin in the Philippines.

Methods

A cost-utility analysis using a decision tree was done to compare the costs and outcomes of carbetocin with oxytocin for PPH prophylaxis among women undergoing either vaginal delivery (VD) or cesarean section (CS) in a six-week time horizon using a societal perspective. One-way and probabilistic sensitivity analyses were applied to investigate parameter uncertainties. Addit

SUBMITTER: Briones JR 

PROVIDER: S-EPMC7586682 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature